Prime Medicine, Inc. (PRME) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Core Insights - The new CEO has outlined strategic priorities focused on long-term capital allocation and building a robust company [1] - The company had approximately 18 programs in the pipeline prior to the CEO's appointment in May [1] Group 1: Strategic Priorities - The CEO emphasizes the importance of making difficult decisions due to the company's success across various initiatives [2] - The strategic focus has been in place since the CEO's earlier involvement with the company starting in January of the previous year [1]